Speaker illustration

Doctor Erin Howden

Baker Heart and Diabetes Institute, Melbourne (Australia)

Associate Professor Erin Howden is a National Heart Foundation Future Leader Fellow and head of the Cardiometabolic Health and Exercise Physiology Lab and lead of the Physical Activity Program at the Baker Heart and Diabetes Institute. Erin’s research program examines the physiological mechanisms underpinning the decline in cardiovascular health and fitness across the healthy aging and heart failure continuum and the role of exercise interventions to improve cardiovascular health. Her research also focuses on the area of Cardio-Oncology, where she is conducting studies to understand who is most at risk of cardiovascular toxicity following cancer treatment and the role of exercise to prevent cardiovascular toxicity.

A male prostate cancer survivor

Event: ESC Preventive Cardiology 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Sex aspects in preventive cardio-oncology: what to look for in the individual patient

Thumbnail

Evidence-based management of long COVID

Event: ESC Preventive Cardiology 2023

Topic: Cardiovascular Rehabilitation

Session: COVID-19 and cardiovascular health: putting the evidence together

Thumbnail

Traditional markers of myocardial dysfunction fail to detect marked reductions in physical capacity amoung chemotherapy patients

Event: EuroEcho 2019

Topic: Imaging in Prevention and Rehabilitation

Session: Imaging: miscellaneous

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb